Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. lowered its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 97.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,570 shares of the company's stock after selling 1,130,618 shares during the quarter. Ameriprise Financial Inc.'s holdings in Surgery Partners were worth $562,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of SGRY. KBC Group NV grew its stake in Surgery Partners by 66.1% in the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock worth $84,000 after purchasing an additional 1,577 shares in the last quarter. MeadowBrook Investment Advisors LLC boosted its position in Surgery Partners by 16.6% during the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock valued at $218,000 after acquiring an additional 1,460 shares in the last quarter. Tower Research Capital LLC TRC boosted its position in Surgery Partners by 279.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock valued at $228,000 after acquiring an additional 7,925 shares in the last quarter. Empowered Funds LLC bought a new stake in Surgery Partners during the 4th quarter valued at $245,000. Finally, KLP Kapitalforvaltning AS bought a new stake in Surgery Partners during the 4th quarter valued at $273,000.

Surgery Partners Price Performance

Shares of SGRY stock traded up $0.02 during mid-day trading on Friday, hitting $23.19. 567,111 shares of the stock were exchanged, compared to its average volume of 1,112,864. Surgery Partners, Inc. has a 52-week low of $19.50 and a 52-week high of $33.97. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The company has a market cap of $2.97 billion, a PE ratio of -48.31, a price-to-earnings-growth ratio of 19.21 and a beta of 1.93. The firm has a fifty day moving average of $22.27 and a 200 day moving average of $22.76.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). The business had revenue of $776.00 million for the quarter, compared to analysts' expectations of $777.77 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business's revenue for the quarter was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.10 EPS. Research analysts anticipate that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have recently commented on SGRY. Royal Bank of Canada reiterated an "outperform" rating and set a $35.00 price objective on shares of Surgery Partners in a research note on Tuesday, March 25th. Benchmark reissued a "buy" rating and set a $35.00 target price on shares of Surgery Partners in a report on Monday, April 21st. Barclays lowered their price target on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 27th. Finally, Macquarie cut their price target on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 11th. One analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $33.56.

Insider Transactions at Surgery Partners

In other news, CFO David T. Doherty sold 6,733 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.02, for a total transaction of $161,726.66. Following the completion of the transaction, the chief financial officer now directly owns 150,868 shares of the company's stock, valued at $3,623,849.36. This represents a 4.27% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Marissa Brittenham sold 3,156 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the transaction, the insider now directly owns 63,408 shares of the company's stock, valued at approximately $1,527,498.72. The trade was a 4.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.30% of the company's stock.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.